In vivo, ketoconazole suppressed orthotopic CT26 tumor growth in the immunocompetent BALB/c mice, but this effect was minimal in the lymphocyte-deficient B-NDG mice (Fig. 5A–C). The gene discussed is DDX53; the disease is neoplasm.